alnustone

N/A

Report date: 2023/02/28 18:03:57

Base Information

Drug Namealnustone
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionThyroid adenoma-associated protein inhibitors
TargetsThyroid adenoma-associated protein
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong University
China Registration ClassN/A

Develop Information

Active CompaniesShandong University
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A